DENGUE FEVER

This study is checking how well an approved dengue vaccine works in real-world public health programs. It will follow 70,000 children and adolescents in Southeast Asia for three years to see if those who get the vaccine are hospitalized for dengue less often than those who don't.…

This study is testing a vaccine designed to prevent dengue fever in adults aged 45 to 79. Researchers want to see how safe the vaccine is and how well it triggers an immune response, especially in older adults and people with other health conditions like diabetes or high blood pr…

This study aims to create a global registry to collect information on people who have both an inherited bleeding disorder (like hemophilia) and a dengue infection. Researchers will look back at past cases and follow new ones to understand how often serious bleeding happens, what …

This study aims to better understand which dengue patients are most likely to need hospital admission or blood transfusions. Researchers will follow 100 patients with confirmed dengue in a Mexican hospital, collecting information about their symptoms and test results. The goal is…